Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
about
Antifungal Therapy: New Advances in the Understanding and Treatment of MycosisVoriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasisClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesDetection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Echinocandin Resistance in Candida.First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.Medically important fungi respond to azole drugs: an update.Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5.Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard.Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa.Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory-based sentinel surveillance, South Africa, 2009-2010.Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.Future Research Priorities in Fungal Resistance.Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.Experimental therapy with azoles against Candida guilliermondii.Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.Pulsed electric field-assisted sensitization of multidrug-resistant Candida albicans to antifungal drugs.Fungal Biofilms and Polymicrobial Diseases.Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei.Hot topics in antifungal susceptibility testing: A new drug, a bad bug, sweeping caspofungin testing under the rug, and solving the ECV shrug.Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories
P2860
Q28818603-F8BDEB39-CB02-4E90-9977-EFF4142CC8E4Q30376282-75FA53AF-2268-4BD2-A6BC-862E068C2EFCQ30797685-C35A83B5-8105-4150-A68A-E68B64E2C626Q30938136-576348A7-BBC3-466D-85A0-46C0B1EC6D88Q33583405-6BEAE9B2-5CA3-4132-9355-DC63FA9F26EFQ34416327-F6B90221-04A6-430B-9DE4-148AF16B9D53Q34505582-91C9EF7B-974B-4DCE-8E73-E045AD7CF7D4Q35076896-28F368E7-8B31-494A-A4B7-95695137EA52Q35688413-8D484332-F8D2-474B-9020-B96C3F96A7B0Q35746090-F354E811-2A0C-43D3-A923-817CA7337E09Q36158263-A2BF59F0-E485-46DD-8225-B6B88B95BED4Q36276186-CE695F9A-B3CC-41F5-A862-674C3A8E8F38Q36503873-DB38EDDA-5A84-4B70-AA64-B3D0AC6887CAQ37580801-0E43DDF5-5FC1-4717-ADE2-FA2C908D372CQ38534865-E3881C58-2EFF-4A2E-A873-4BF247B5FC61Q38559208-07BA5091-E6F0-459A-AC07-CC6847741392Q38684199-2CFB621C-1053-483F-8D90-AA1029CFC30CQ38959280-5212DD53-9A20-4637-AE17-1032CCA0E56FQ39030370-66F40E83-9FFB-4827-93CD-2D90CA5CAE7DQ39203378-FE78DF20-790D-4B95-8EBE-D612D0187CE8Q39420285-B70D342D-0B0E-44CD-B196-95550C92AE29Q40045680-26DE6B6E-2605-4E48-A2CD-E496E0634CA1Q40051828-6F89CDAB-F675-458F-9FDE-85DDABA9E3A5Q40169961-F713133D-8A11-4CBF-8AB7-D1D7BD5FCCCDQ40750682-ADFB220C-9735-4C21-953A-52A926944B17Q41511867-45E15D18-B1C8-4E21-938E-080113539B6CQ41702288-D1E39AAA-93D2-4BD7-A62B-0C9EE061B727Q42217003-1DE3F81E-9EC7-4464-B9BF-7807AE14DB7EQ42657625-5E5EC5C7-9B08-428C-AA55-57D60D318C9DQ42676608-7FC32CA5-EB9B-441E-82D9-71B11FD13016Q46660786-509480FC-8851-4131-AC62-3C18C84ECED2Q47789181-420A62BF-61FE-4346-B27E-E142C0696229Q49679766-C3919143-CC5F-4AA4-BCE2-B2194E73B2D6Q50053143-C2CFA47E-2EE4-48CF-9B59-BB3367EC9A7EQ53779321-5B0DDF62-1F15-4CAC-9595-8FFBCABCDC38Q58701180-7CC467B1-00C0-4E75-A6BE-DAE12DFEB13A
P2860
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@ast
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@en
type
label
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@ast
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@en
prefLabel
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@ast
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@en
P2093
P2860
P50
P356
P1476
Multilaboratory study of epide ...... osaconazole, and voriconazole.
@en
P2093
A Espinel-Ingroff
A Fothergill
C Lass-Flörl
G M Gonzalez
G St-Germain
J Turnidge
L Ostrosky-Zeichner
L X Bonfietti
P2860
P304
P356
10.1128/AAC.02615-13
P407
P577
2014-01-13T00:00:00Z